The treatment for mantle cell lymphoma can involve everything from watching and waiting to receiving stem cells, according to the Lymphoma Research Foundation. The treatment options as of 2015 vary depending on the stage of the cancer, the age of the patient and the patient's general health.
Some patients with a small amount of cancer that is not causing symptoms may simply require monitoring, as explained by the Lymphoma Research Foundation. However, since most cases of mantle cell lymphoma are not discovered until after the cancer has spread throughout the body, most patients receive some type of treatment.
For young patients, a combination of chemotherapy and an antibody called rituximab is the first course of treatment, according to the Lymphoma Research Foundation. It is often followed by a stem cell transplant and then a series of aggressive induction therapies. For older patients, a course of rituximab is typically followed by several combinations of chemotherapy drugs.
Several new medications for mantle cell lymphoma have been approved, and others are in development as of 2015, as reported by the Lymphoma Research Foundation. Clinical trials are ongoing and are expected to be successful in identifying the appropriate treatment of this rare disease.
Patients who go into remission are advised to continue getting medical evaluations, as the Lymphoma Research foundation explains. Blood tests and CAT scans can determine if and when additional treatment is necessary.